MEDA  |
| Names |
| IUPAC name 1-(8-methoxy-2,3-dihydro-1,4-benzodioxin-6-yl)propan-2-amine |
| Identifiers |
| | |
3D model (JSmol) | |
| ChemSpider | |
| ECHA InfoCard | 100.032.914  |
| KEGG | |
| | |
| | |
InChI InChI=1S/C12H17NO3/c1-8(13)5-9-6-10(14-2)12-11(7-9)15-3-4-16-12/h6-8H,3-5,13H2,1-2H3  Key: NRVFDGZJTPCULU-UHFFFAOYSA-N  InChI=1S/C12H17NO3/c1-8(13)5-9-6-10(14-2)12-11(7-9)15-3-4-16-12/h6-8H,3-5,13H2,1-2H3 Key: HEYPARQBPGSFKW-UHFFFAOYSA-N
|
SMILES NC(CC1=CC2=C(OCCO2)C(OC)=C1)C
|
| Properties |
Chemical formula | C12H17NO3 |
| Molar mass | 223.272 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
| | |
MEDA (3-methoxy-4,5-ethylenedioxyamphetamine) is a lesser-known psychedelic drug. MEDA was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 200 mg, and the duration unknown.[1] MEDA produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MEDA.
See also
References
This article is copied from an
article on Wikipedia® - the free encyclopedia created and edited by its online user community. The text was not checked or edited by anyone on our staff. Although the vast majority of Wikipedia® encyclopedia articles provide accurate and timely information, please do not assume the accuracy of any particular article. This article is distributed under the terms of
GNU Free Documentation License.
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.
)
